Magnesium Sulfate Injection, USP, 50% (25 grams/50 mL), For IM or IV Use, 50 mL, Single Dose Vial, Rx only, Preservative Free, APP Pharmaceuticals, LLC, Schaumburg, IL, 60173, NDC 63323-064-50
Published September 4, 2013 · Recall initiated: May 25, 2013
Summary
FDA records drug Class I recall D-920-2013, published September 4, 2013 and initiated May 25, 2013. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 15,625 vials; Lot: Lot #: 6103882, Exp 10/14. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Glass particulate matter was observed in a retention sample during an annual review.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Fresenius Kabi USA, LLC
- Distributor
- Nationwide
- Lot
- Lot #: 6103882, Exp 10/14
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by FreseniusSeptember 2, 2026
- FDAMorphine Sulfate Injection, USP, 2 mg /mL, 1 mL single-dose Simplist prefilled syringes, For Intramuscular orAugust 26, 2026
- FDAGlycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only,July 29, 2026
- FDAXylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL,July 29, 2026
- FDAENTERIC COATED ASPIRIN (NSAID), 81 mg, 120-count tablets per bottle, distributed by: Rugby Laboratories, Inc.,September 4, 2013
- FDABethel 30 capsules, packaged in 30 count bottles, Distributed by BETHEL INC. New York, New YorkSeptember 4, 2013
Questions about this recall
Was Magnesium Sulfate Injection, USP, 50% (25 grams/50 mL), For IM or IV Use, 50 mL, Single Dose Vial, Rx only, Preservative Free, APP Pharmaceuticals, LLC, Schaumburg, IL, 60173, NDC 63323-064-50 recalled?
Yes. FDA published recall D-920-2013 on September 4, 2013. Reported hazard: Presence of Particulate Matter: Glass particulate matter was observed in a retention sample during an annual review.
What should I do if I have this product?
Voluntary: Firm initiated · Letter